Sari la conținut

Română · beta. Traducerea a fost făcută automat și este încă în curs de revizuire. Citește pagina în engleză

perspectiva aiqbenchPolitici AI

analiza aiqbench

Utah's regulatory approval marks a significant policy shift allowing an AI system to autonomously issue prescription refills for acne treatments with minimal human oversight. This development highlights the evolving intersection of healthcare regulation and autonomous machine learning capabilities, setting a precedent for future AI-driven clinical decision-making.
Sursă care acoperăSiliconANGLE
Ce este aceastaLectura unui model asupra articolului și a acoperirii conexe, scrisă pentru aiqbench. Nu sunt cuvintele publicației.

Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments

SiliconANGLE5 min de cititArticolul și perspectiva sunt în engleză.

Utah has become the first state in the U.S. to give an artificial intelligence startup permission to automate the approval of prescription refills with only minimal oversight from human physicians. In a blog post today, Nolla Health said it has been granted approval by the state to launch a pilot project that will enable acne […] The post Utah gives startup Nolla Health permission to start issuing AI automated prescriptions for acne treatments appeared first on SiliconANGLE.

Utah has become the first state in the U.S. to give an artificial intelligence startup permission to automate the approval of prescription refills with only minimal oversight from human physicians. In a blog post, Nolla Health said it has been granted approval by the state to launch a pilot project that will enable acne sufferers to talk to an AI agent, upload a photo of their face, and then automatically receive a prescription without speaking to a doctor. “This makes Nolla the first ever end-to-end AI doctor,” said Nolla Health founder Luis Wenus in a post on X…

Extras afișat conform termenilor RSS ai publicației · 98 cuvinte · textul integral și figurile sunt pe site-ul publicației

Subiecte conexe